Updates from SGO 2024

Insights from 2024 SGO Annual Meeting
B

SGO 2024 Insights: "innovaTV 301/ENGOT-cx12/GOG-3057 Study - Efficacy & Safety of Tisotumab Vedotin vs. Investigator's Choice of Chemo in 2L/3L Recurrent/Metastatic Cervical Cancer"

By Insights from 2024 SGO Annual Meeting FEATURING Brian Slomovitz
By Insights from 2024 SGO Annual Meeting FEATURING Brian Slomovitz
312 views
April 12, 2024
Comments 0
Login to view comments. Click here to Login
11:50

Updates in the Management of Locally Advanced Cervical Cancer

Jill Remick

106 views
05:13

ESMO 2024 Summary: Advances in Cervical Cancer Management - Comprehe…

2024 ESMO Annual Meeting Insights Hub

D. Lorusso

186 views
20:16

Updates on Surgical Trials in Gynecologic Oncology

OncoAlert

N. Bizzarri

64 views
14:27

The Management of Gynecological Cancers With Limited Resources

OncoAlert

H. Tayzar Soe

73 views
09:06

ASCO® 2024 Summary: "Gynecologic Oncology Updates"

2024 ASCO® Annual Meeting Insights Hub

R. Salani

1.6K views
25:38

Updates in the Management of Cervical Cancer

Abdulrahman Sinno

383 views
16:54

Precision Medicine: Management of Cervical Cancer

Miami Cancer Institute Precision Oncology Symposium

J. Diaz

239 views
17:20

Antibody Drug Conjugates in Gynecologic Oncology: From Bench to Beds…

UCLA Health

G. Konecny

326 views
09:01

Multidisciplinary Approach to Eye Care in Patients With Cervical Can…

UChicago Medicine

A. Farooq

303 views
09:07

ESGO 2024 Insights: "SENTIX Trial - Survival of Patients With Early …

Insights from 2024 ESGO Annual Meeting

D. Cibula

234 views
04:02

2024 Updates in Cervical Cancer

Total Health

T. Tillmanns

499 views
13:41

2024 Updates in Locally Advanced Cervical Cancer

UCLA Health

D. Chase

418 views